Received May 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
hadn't received the 2nd dose yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 57-year-old male patient who received HAV (Havrix) for prophylaxis. Previously administered products included Havrix (received 1st dose of Havrix 1 year ago). On an unknown date, the patient did not receive the 2nd dose of Havrix. On an unknown date, an unknown time after receiving Havrix, the patient experienced incomplete course of vaccination (Verbatim: hadn't received the 2nd dose yet). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 09-MAY-2025 The pharmacist called to inform that a patient had received only one dose of Havrix one year ago (no exact date available), and hadn't received the 2nd dose yet. The Vaccine Administration Facility is the same as Primary Reporter. Till the time of reporting the patients did not receive the second dose of Havrix, which led to incomplete course of vaccination.